Abiomed begins STEMI DTU RCT trial of Impella CP heart pump
Abiomed has started the ST-elevation myocardial infarction door-to-unloading (STEMI DTU) pivotal randomised controlled trial (RCT) to further demonstrate the safety and effectiveness of Impella heart pump. The study